KIMBERLY BEREL: Open Payments
NPI 1568854115 · SLIDELL, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$765 in 43 payments from 17 companies in 2025. Trend: 2023 $1,318 · 2024 $1,403 · 2025 $765
Food & beverage: $765
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $157 |
| Exact Sciences Corporation | 5 | $101 |
| Lilly USA, LLC | 5 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| ABBVIE INC. | 3 | $49 |
| Edwards Lifesciences Corporation | 1 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| PFIZER INC. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
Products named: Cologuard Collection Kit, Ozempic, Kerendia, MOUNJARO, VRAYLAR, Wegovy, Rybelsus, REXULTI.
Industry payments across LA — which companies pay providers there.
